Page last updated: 2024-08-26

sr141716 and Hepatitis

sr141716 has been researched along with Hepatitis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Hassan, R; Mahmoud, MF; Rezq, S1

Other Studies

1 other study(ies) available for sr141716 and Hepatitis

ArticleYear
Rimonabant ameliorates hepatic ischemia/reperfusion injury in rats: Involvement of autophagy via modulating ERK- and PI3K/AKT-mTOR pathways.
    International immunopharmacology, 2021, Volume: 100

    Topics: Animals; Autophagy; Autophagy-Related Proteins; Cannabinoid Receptor Antagonists; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Hepatitis; Inflammation Mediators; Lipid Peroxidation; Liver; Liver Cirrhosis; Male; Oxidative Stress; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Rats, Wistar; Receptor, Cannabinoid, CB1; Reperfusion Injury; Rimonabant; Signal Transduction; TOR Serine-Threonine Kinases

2021